Metropolitan Life Insurance Company (MetLife)’s ArcBest ARCB Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ARCB Stock Details ARCB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,247	Closed	-$178K	–	164
2024 Q1	$178K	Sell	1,247 -85	-6%	-$11.1K	0.01%	768
2023 Q4	$160K	Sell	1,332 -63	-5%	-$6.98K	0.01%	846
2023 Q3	$142K	Buy	1,395 +69	+5%	+$7.24K	0.01%	842
2023 Q2	$131K	Buy	1,326 +36	+3%	+$3.22K	0.01%	880
2023 Q1	$119K	Sell	1,290 -215	-14%	-$19.3K	0.01%	917
2022 Q4	$105K	Buy	1,505 +84	+6%	+$6.49K	﹤0.01%	1028
2022 Q3	$103K	Hold	1,421	–	–	﹤0.01%	1000
2022 Q2	$100K	Sell	1,421 -164	-10%	-$12.1K	﹤0.01%	1051
2022 Q1	$128K	Sell	1,585 -4,871	-75%	-$439K	﹤0.01%	1051
2021 Q4	$774K	Sell	6,456 -140	-2%	-$14.2K	0.01%	1141
2021 Q3	$539K	Sell	6,596 -639	-9%	-$42.1K	0.01%	1410
2021 Q2	$421K	Buy	7,235 +363	+5%	+$26K	0.01%	1625
2021 Q1	$484K	Sell	6,872 -1,305	-16%	-$75.2K	0.01%	1439
2020 Q4	$349K	Hold	8,177	–	–	0.01%	1600
2020 Q3	$254K	Hold	8,177	–	–	﹤0.01%	1631
2020 Q2	$217K	Hold	8,177	–	–	﹤0.01%	1741
2020 Q1	$143K	Buy	8,177 +321	+4%	+$7.38K	﹤0.01%	1801
2019 Q4	$217K	Sell	7,856 -512	-6%	-$14.8K	﹤0.01%	1862
2019 Q3	$255K	Hold	8,368	–	–	﹤0.01%	1714
2019 Q2	$235K	Hold	8,368	–	–	﹤0.01%	1791
2019 Q1	$258K	Hold	8,368	–	–	﹤0.01%	1730
2018 Q4	$287K	Buy	8,368 +800	+11%	+$31K	0.01%	1572
2018 Q3	$367K	Sell	7,568 -1,324	-15%	-$62.2K	0.01%	1589
2018 Q2	$406K	Hold	8,892	–	–	0.01%	1460
2018 Q1	$285K	Hold	8,892	–	–	﹤0.01%	1655
2017 Q4	$318K	Sell	8,892 -9,625	-52%	-$328K	﹤0.01%	1581
2017 Q3	$619K	Hold	18,517	–	–	﹤0.01%	1540
2017 Q2	$381K	Hold	18,517	–	–	﹤0.01%	1894
2017 Q1	$481K	Hold	18,517	–	–	﹤0.01%	1671
2016 Q4	$512K	Hold	18,517	–	–	﹤0.01%	1707
2016 Q3	$352K	Sell	18,517 -669	-3%	-$12.1K	﹤0.01%	1948
2016 Q2	$312K	Hold	19,186	–	–	﹤0.01%	2006
2016 Q1	$414K	Hold	19,186	–	–	﹤0.01%	1701
2015 Q4	$410K	Hold	19,186	–	–	﹤0.01%	1748
2015 Q3	$494K	Hold	19,186	–	–	﹤0.01%	1646
2015 Q2	$610K	Buy	+19,186	New	+$685K	﹤0.01%	1612
2015 Q1	–	Sell	-20,528	Closed	-$952K	–	2228
2014 Q4	$952K	Hold	20,528	–	–	0.01%	1344
2014 Q3	$766K	Buy	20,528 +1,112	+6%	+$42.2K	0.01%	1447
2014 Q2	$845K	Sell	19,416 -2,301	-11%	-$93.3K	0.01%	1469
2014 Q1	$802K	Hold	21,717	–	–	0.01%	1502
2013 Q4	$731K	Hold	21,717	–	–	0.01%	1548
2013 Q3	$557K	Hold	21,717	–	–	﹤0.01%	1695
2013 Q2	$498K	Buy	+21,717	New	+$337K	﹤0.01%	1698

Other funds holding ARCB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ARCB Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of ArcBest (ARCB) in Q2 2024, closing a stake of 1,247 shares — an estimated $178K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ARCB in Q2 2013 and held it in 43 quarters. The position peaked at $952K in Q4 2014. 299 funds tracked by Wall St. Rank hold ARCB as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining ArcBest position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 1,247 ArcBest shares in Q2 2024, an estimated $178K.
Metropolitan Life Insurance Company (MetLife) first reported a position in ArcBest in Q2 2013 and held it in 43 quarters.
Metropolitan Life Insurance Company (MetLife)'s ArcBest position peaked at $952K in Q4 2014.
299 funds tracked by Wall St. Rank held ArcBest as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.